Phenanthroline

Phenanthroline

SCHEMBL635069

[Pd].c1cnc2c(c1)ccc1cccnc12

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.94
CCR8 P51685 5/20 0.94
LMNA P02545 4/20 0.94
CCR5 P51681 3/20 0.94
KDM4E B2RXH2 3/20 0.94
MMP2 P08253 2/20 0.94
TSHR P16473 2/20 0.94
MAPT P10636 2/20 0.94
HTT P42858 2/20 0.94
SMN1; SMN2 Q16637 2/20 0.94
TDP1 Q9NUW8 2/20 0.94
GMNN O75496 1/20 0.94
TP53 P04637 1/20 0.94
HSP90AA1 P07900 1/20 0.94
CYP3A4 P08684 1/20 0.94
CYP2D6 P10635 1/20 0.94
MMP9 P14780 1/20 0.94
ALOX15 P16050 1/20 0.94
NFKB1 P19838 1/20 0.94
MMP8 P22894 1/20 0.94

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenanthroline SCHEMBL7730730 1.00 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL29367277 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL29354015 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL8312 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL8845760 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL22982126 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL22462277 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL21300488 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL21060516 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL21044608 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113903934-B Preparation method and application of porous Pd-PdO nanorods 先进能源产业研究院(广州)有限公司 2023-12-08 CN claimed
CN-117107367-A Method for obtaining On-DNA aromatic compound through Suzuki coupling reaction and application thereof 晶泰智药技术(上海)有限公司 2023-11-24 CN claimed
CN-110359097-B Method for obtaining On-DNA aromatic hydrocarbon compound through Suzuki coupling reaction in construction of DNA coding compound library 上海药明康德新药开发有限公司 2022-09-20 CN claimed
CN-110331447-B Method for preparing On-DNA aryl alkyne compound in construction of DNA coding compound library 上海药明康德新药开发有限公司 2022-05-27 CN claimed
CN-113903934-A Preparation method and application of porous Pd-PdO nanorod 先进能源产业研究院(广州)有限公司 2022-01-07 CN claimed
CN-112851733-A Method for preparing C-C coupling product based On-DNA aryl diazonium salt intermediate 重庆大学 2021-05-28 CN claimed
CN-110359097-A The method that On-DNA aromatic compound is obtained by Suzuki coupling reaction in the building of DNA encoding compound library 上海药明康德新药开发有限公司 2019-10-22 CN claimed
CN-110331447-A The method of On-DNA aryl acetylene hydrocarbon compound is prepared in the building of DNA encoding compound library 上海药明康德新药开发有限公司 2019-10-15 CN claimed
US-9751906-B2 Selective oxidation of carbohydrates RIJKSUNIVERSITEIT GRONINGEN (NL) 2017-09-05 US claimed
US-20150218196-A1 SELECTIVE OXIDATION OF CARBOHYDRATES RIJKSUNIVERSITEIT GRONINGEN (NL) 2015-08-06 US claimed
EP-2864343-A1 SELECTIVE OXIDATION OF CARBOHYDRATES Rijksuniversiteit Groningen (NL) 2015-04-29 EP claimed
WO-2013191549-A1 SELECTIVE OXIDATION OF CARBOHYDRATES RIJKSUNIVERSITEIT GRONINGEN (NL) 2013-12-27 WO claimed
JP-61218592-A None JP disclosed
CN-119916644-A Photosensitive resin composition containing alkynyl anthracene photosensitizer and application thereof 湖南初源新材料股份有限公司 2025-05-02 CN disclosed
EP-4508054-A1 PREPARATION OF ORGANOSILICON COMPOUNDS WITH VINYLESTER FUNCTIONALITY Dow Global Technologies LLC (US) 2025-02-19 EP disclosed
CN-119233667-A Pixel structure for improving brightness and service life of light-emitting element and display 广西自贸区睿显科技有限公司 2024-12-31 CN disclosed
US-4996282-A Using transvinylation polyhydric alcohol DESOTO, INC. (US) 1991-02-26 US disclosed
WO-1990003989-A1 CATIONICALLY CURABLE POLYURETHANE COMPOSITIONS HAVING VINYL ETHER FUNCTIONALITY DESOTO, INC. (US) 1990-04-19 WO disclosed
JP-S61218592-A 10,10-BIS((TRIMETHYLSILYLOXY))-12,12-DIMETHYL-3,6,11-TRIOXA-10,12-DISILATRIDECENE-1 ASAHI GLASS CO LTD 1986-09-29 JP disclosed
US-4013691-A PROCESS FOR THE SIMULTANEOUS MANUFACTURE OF EPSILON-CAPROLACTONES AND CARBOXYLIC ACIDS MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1977-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218196-A1 SELECTIVE OXIDATION OF CARBOHYDRATES HAO2, HAO1, HAAO CCR1 1342/4885CCR8 1957/4885LMNA 4516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.